Fresenius Medical Care reported EUR817M in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Akzo Nobel EUR 388M 10M Sep/2026
Alcon AG USD 728M 72M Sep/2026
AstraZeneca USD 7.46B 2.3B Sep/2026
Bayer EUR 1.62B 529M Sep/2026
Beiersdorf EUR 926M 58M Jun/2026
DaVita Healthcare Partners USD 664.44M 82.37M Sep/2026
Demant DKK 2.8B 47M Jun/2026
E.ON EUR 1.7B 447M Sep/2026
Essilor EUR 4.34B 1.25B Jun/2026
Fresenius EUR 912M 76M Sep/2026
Fresenius Medical Care EUR 817M 26.66M Sep/2026
Genmab DKK 401M 186M Jun/2026
Getinge SEK 1.89B 1.58B Jun/2026
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 3.51B 734M Jun/2026
GN Store Nord DKK 354M 2M Sep/2026
GRIFOLS EUR 505M 32M Sep/2026
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.68B 82.6M Sep/2026
Novartis USD 8.62B 2.14B Sep/2026
Philips EUR 772M 138M Sep/2026
Roche Holding CHF 13.43B 744M Jun/2026
RWE EUR 1.56B 184M Sep/2026
Sanofi EUR 5.79B 2.1B Sep/2026
SAP EUR 3.36B 1000K Sep/2026
Smith & Nephew USD 796M 139M Dec/2025